Abstract :

Introduction: Breast cancer is the most common cancer amongst women, which is treated by a multi-modality approach consisting of surgery, chemotherapy, radiotherapy, hormonal therapy, targeted therapy and immunotherapy.

Objective: The aim of the study is to compare the early and late treatment toxicities and the local recurrence following Conventional and Hypofractionated External Beam Radiotherapy in breast cancer patients after surgery.

Methods: A randomized study was conducted for two years including 150 patients. The patients were divided into two arms, with Arm-A receiving a total dose of 50Gy/25# and the Arm-B receiving 40Gy/16#.

Results: Early and late treatment toxicities were comparable in both the arms, except for skin toxicity which was more in the hypofractionated arm (Arm-B).  Local Recurrence was observed in Arm-A in 1 patient at Month 17 of follow-up, and in Arm-B at Month 13 in 1 patient and at Month 21 in 1 patient.

Conclusion: Hypofractionated radiotherapy given over a short period of time is comparable to Conventional fractionation radiotherapy without any significant statistical difference in terms of toxicities or local recurrence; with an added advantage of reduced treatment time, reduced duration of hospital stays, better patients’ compliance and reduced cost of treatment.

---

Keywords :

breast cancer, Conventional, Hypofractionated, Radiotherapy, Recurrence

---

References :

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018 Nov; 68(6):394-424.
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015 Mar; 136(5):359-86.
3. Asthana S, Chauhan S, Labani S. Breast and cervical cancer risk in India: An update. Indian J Public Health 2014 Jan; 58(1):5.
4. American Joint Committee on Cancer. In: Mahul B. Amin, editor. AJCC Cancer Staging Manual, 8th ed. Chicago: Springer; 2017:55-162.
5. Mustacchi P. Ramazzini and Rigoni-Stern on Parity and Breast Cancer: Clinical Impression and Statistical Corroboration. Arch Intern Med 1961 Oct; 108(4):639-42.
6. Kvaale G, Heuch I, Eide GE. A prospective study of reproductive factors and breast cancer: I. Parity. American J Epi 1987; 126(5):831-41.
7. Sattin RW, Rubin GL, Webster LA, Huezo CM,Wingo PA, Ory HW et al. Family history and the risk of breast cancer. Jama 1985 Apr; 253(13):1908-13.
8. Goldin BR, Adlercreutz H, Gorbach SL, Woods MN, Dwyer JT, Conlon T, et al. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 1986 Dec; 44(6):945-53.
9. Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG, Cantor KP, Miller MD, et al. Active smoking and second-hand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tobacco control 2011 Jan 1; 20(1): e2.
10. Wesley Horton A. Indoor tobacco smoke pollution a major risk factor for both breast and lung cancer? Cancer 1988 Jul; 62(1):6-14.
11. Page DL, Dupont WD. Histopathologic risk factors for breast cancer in women with benign breast disease. Semin Surg Oncol 1988; 4:213-7.
12. Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G. Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis. Cancer epidemiology 2017 Jun; 48:140-6.
13. Litière S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR, Van Limbergen E, Baaijens MH, et al. Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20-year follow-up of the EORTC 10801 phase 3 randomised trial. The lancet Oncol 2012 Apr; 13(4):412-9.
14. Prakash JS, Luther A, Deodhar M. Modified Radical Mastectomy and Wound Drainage. www.webmedcentral.com/article_view/GENERAL SURGERY 2015; 6(3): WMC004822 (Published on: 02 Mar 2015)
15. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005 Dec; 366:2087–106.
16. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM et al. START Trialists’ Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008 Mar; 371(9618):1098-7.
17. Remick J, Amin NP. Postmastectomy Breast Cancer Radiation Therapy. [Updated 2022 Jan 4]. In: Treasure Island (FL): Stat Pearls Publishing; 2022 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519034.
18. Koulis TA, Phan T, Olivotto IA. Hypofractionated whole breast radiotherapy: current perspectives. Breast Cancer: Targets and Therapy 2015; 7:363.
19. Rastogi K, Jain S, Bhatnagar AR, Bhaskar S, Gupta S, Sharma N. A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients. Asia Pac J Oncol Nurs 2018 Jan; 5(1):107.
20. Agarwal G, Ramakant P. Breast cancer care in India: the current scenario and the challenges for the future. Breast care 2008; 3(1):21-7.
21. Gupta A, Shridhar K, Dhillon PK. A review of breast cancer awareness among women in India: Cancer literate or awareness deficit? European Journal of Cancer 2015 Sep; 51(14):2058-66.
22. Kaushal M, Mishra AK, Sharma J, Zomawia E, Kataki A, Kapur S, et al. (2012) Genomic Alterations in Breast Cancer Patients in Betel Quid and Non-Betel Quid Chewers. PLoS ONE 7(8): e43789. https://doi.org/10.1371/journal.pone.00437 89
23. Schatzkin A, Piantadosi S, Miccozzi M, Bartee D. Alcohol consumption and breast cancer: a cross-national correlation study. International journal of epidemiology 1989 Mar; 18(1):28-31.
24. Sandhu DS, Sandhu S, Karwasra RK, Marwah S. Profile of breast cancer patients at a tertiary care hospital in north India. Indian journal of cancer 2010 Jan; 47(1):16.
25. Kumar A, Bhagabaty SM, Tripathy JP, Selvaraj K, Purkayastha J, Singh R. Delays in diagnosis and treatment of breast cancer and the pathways of care: a mixed methods study from a tertiary cancer centre in North East India. Asian Pacific Journal of Cancer Prevention: APJCP 2019; 20(12):3711.
26. Ferreira KA, Kimura M, Teixeira MJ, Mendoza TR, da Nóbrega JC, Graziani SR, Takagaki TY. Impact of cancer-related symptom synergisms on health-related quality of life and performance status. Journal of pain and symptom management 2008 Jun; 35(6):604-16.
27. Rummel S, Hueman MT, Costantino N, Shriver CD, Ellsworth RE. Tumour location within the breast: Does tumour site have prognostic ability? Ecancermedicalscience. 2015 Jul; 9:552.
28. Raina V, Bhutani M, Bedi R, Sharma A, Deo SVet al. Clinical features and prognostic factors of early breast cancer at a major cancer centre in North India. Indian journal of cancer 2005 Jan; 42(1):40.
29. Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF. Hormone receptor status of breast cancer in India: a study of 798 tumours. The breast 2000 Oct; 9(5):267-70.
30. Kakarala M, Rozek L, Cote M, Liyanage S, Brenner DE. Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the US-a SEER analysis. BMC cancer 2010 Dec; 10(1):1-8.
31. Porock D, Kristjanson L. Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings. Eur J Cancer Care 1999 Sep; 8(3):143-53.
32. Schmeel LC, Koch D, Schmeel FC, Röhner F, Schoroth F, Bücheler BM, et al. Acute radiation-induced skin toxicity in hypofractionated vs conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry. Radiotherapy and Oncology 2020 May; 146:172-9.
33. Tortorelli G, Di Murro L, Barbarino R, Cicchetti S, di Cristino D, Falco MD, et al. Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities. BMC cancer 2013 Dec; 13(1):1-9.
34. Stewart JR, Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995 Mar; 31(5):1205-11.
35. Meattini I, Poortmans PM, Aznar MC, Becherini C, Bonzano E, Cardinale D, et al. Association of breast cancer irradiation with cardiac toxic effects: A narrative review. JAMA Oncol 2021 Jun; 7(6):924-32.
36. Palumbo I, Mariucci C, Falcinelli L, et al. Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early-stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity. Breast Cancer 2019; 26(3):290-304.
37. Movsas B, Raffin TA, Epstein AH, Link CJ. Pulmonary radiation injury. Chest 1997 Apr; 111(4):1061-76.
38. Olsen NK, Pfeiffer P, Johannsen L, Schrøder H, Rose C. Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys 1993 Apr; 26(1):43-9.
39. Recht A, Silen W, Schnitt SJ, Connolly JL, Gelman RS, et al. Time-course of local recurrence following conservative surgery and radiotherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 1988 Aug; 15(2):25